Chicago Capital, LLC Procept Bio Robotics Corp Transaction History
Chicago Capital, LLC
- $3.51 Billion
- Q1 2025
A detailed history of Chicago Capital, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Chicago Capital, LLC holds 422,373 shares of PRCT stock, worth $23 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
422,373
Previous 379,582
11.27%
Holding current value
$23 Million
Previous $30.6 Million
19.49%
% of portfolio
0.7%
Previous 0.82%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
292Shares Held
39.9MCall Options Held
196KPut Options Held
142K-
Vanguard Group Inc Valley Forge, PA5.13MShares$279 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$190 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$95.4 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$77 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$64.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.43B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...